Mounjaro, a novel medication from Eli Lilly , is generating significant buzz within the diabetes world. This subcutaneous medication works in a distinct way, targeting multiple hormones involved in blood sugar control : GIP and GLP-1. Early studies suggest it may provide significant improvements